ASRS
Arizona State Retirement System Portfolio holdings
AUM
$17.4B
1-Year Return
25.34%
This Quarter Return
+9.99%
1 Year Return
+25.34%
3 Year Return
+111.8%
5 Year Return
+199.95%
10 Year Return
+467.9%
AUM
$12.3B
AUM Growth
+$1.18B
(+11%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
2.42%
Top 10 Holdings %
Top 10 Hldgs %
26.36%
Holding
2,282
New
63
Increased
688
Reduced
1,425
Closed
105
Top Buys
| 1 |
Apple
AAPL
|
+$34.7M |
| 2 |
Microsoft
MSFT
|
+$29.9M |
| 3 |
Tesla
TSLA
|
+$21.6M |
| 4 |
Amazon
AMZN
|
+$17.2M |
| 5 |
NVIDIA
NVDA
|
+$14.5M |
Top Sells
| 1 |
Technology Select Sector SPDR Fund
XLK
|
+$24.6M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$12.1M |
| 3 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$1.75M |
| 4 |
Crane NXT
CXT
|
+$1.53M |
| 5 |
D.R. Horton
DHI
|
+$1.31M |
Sector Composition
| 1 | Technology | 28.59% |
| 2 | Healthcare | 13.34% |
| 3 | Financials | 11.83% |
| 4 | Consumer Discretionary | 11.29% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
MaxCyte
MXCT
$151M
| $113K | ﹤0.01% |
24,568
+3,870
| +19% | +$17.8K |
|
|
TRTX
2102
TPG RE Finance Trust
TRTX
$747M
| $113K | ﹤0.01% |
15,194
-506
| -3% | -$3.75K |
|
2103
Lyell Immunopharma
LYEL
$253M
| $111K | ﹤0.01% |
+1,753
| New | +$111K |
|
2104
W&T Offshore
WTI
$257M
| $111K | ﹤0.01% |
28,797
-240
| -0.8% | -$929 |
|
2105
GoodRx Holdings
GDRX
$1.43B
| $110K | ﹤0.01% |
20,015
-293
| -1% | -$1.62K |
|
2106
Aldeyra Therapeutics
ALDX
$346M
| $110K | ﹤0.01% |
+13,162
| New | +$110K |
|
2107
OraSure Technologies
OSUR
$245M
| $107K | ﹤0.01% |
21,323
+1,333
| +7% | +$6.68K |
|
|
WW
2108
DELISTED
WW International
WW
| $107K | ﹤0.01% |
+15,863
| New | +$107K |
|
2109
iHeartMedia
IHRT
$339M
| $106K | ﹤0.01% |
29,075
-4,442
| -13% | -$16.2K |
|
2110
HarborOne Bancorp
HONE
$555M
| $106K | ﹤0.01% |
12,188
-639
| -5% | -$5.55K |
|
2111
Alector
ALEC
$283M
| $105K | ﹤0.01% |
17,491
+1,915
| +12% | +$11.5K |
|
2112
Vanda Pharmaceuticals
VNDA
$266M
| $105K | ﹤0.01% |
15,950
-447
| -3% | -$2.95K |
|
2113
Montauk Renewables
MNTK
$285M
| $105K | ﹤0.01% |
14,123
-4,601
| -25% | -$34.2K |
|
|
OPI
2114
Office Properties Income Trust
OPI
$17M
| $105K | ﹤0.01% |
13,641
-431
| -3% | -$3.32K |
|
2115
Fate Therapeutics
FATE
$113M
| $105K | ﹤0.01% |
22,057
-467
| -2% | -$2.22K |
|
2116
Axogen
AXGN
$756M
| $104K | ﹤0.01% |
11,368
-272
| -2% | -$2.48K |
|
|
SLGC
2117
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $104K | ﹤0.01% |
44,858
+4,106
| +10% | +$9.49K |
|
2118
Babcock & Wilcox
BW
$203M
| $103K | ﹤0.01% |
17,448
-529
| -3% | -$3.12K |
|
2119
ImmunityBio
IBRX
$2.43B
| $102K | ﹤0.01% |
36,725
+1,928
| +6% | +$5.36K |
|
|
NXDR
2120
Nextdoor Holdings
NXDR
$786M
| $101K | ﹤0.01% |
30,951
+4,654
| +18% | +$15.2K |
|
|
ONL
2121
Orion Office REIT
ONL
$169M
| $99.9K | ﹤0.01% |
15,113
-1,297
| -8% | -$8.57K |
|
2122
Scilex Holding
SCLX
$175M
| $99.7K | ﹤0.01% |
512
| – | – |
|
2123
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $99.6K | ﹤0.01% |
23,337
+5,308
| +29% | +$22.7K |
|
|
QVCGA
2124
QVC Group, Inc. Series A Common Stock
QVCGA
$72.7M
| $98.9K | ﹤0.01% |
1,998
-60
| -3% | -$2.97K |
|
2125
Summit Therapeutics
SMMT
$14B
| $98.4K | ﹤0.01% |
+39,193
| New | +$98.4K |
|